Literature DB >> 1930196

Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor).

T K Yeo1, D R Senger, H F Dvorak, L Freter, K T Yeo.   

Abstract

The hyperpermeability of the microvasculature supplying solid tumors is largely attributable to a heterodimeric Mr 34,000-43,000 tumor-secreted protein, vascular permeability factor. Upon reduction, the vascular permeability factor secreted by line 10 tumor cells is resolved by SDS-PAGE into 3 discrete bands of Mr 24,000, 19,500, and 15,000. We demonstrate here that line 10 vascular permeability factor is an N-linked glycoprotein. Nonglycosylated vascular permeability factor migrates on reduced SDS-PAGE as two bands of Mr 20,000 and 15,000. Pulse-chase studies demonstrated that all three chains of native vascular permeability factor were secreted rapidly following synthesis and at equal rates, with a cellular half-retention time of approximately 37 min. When glycosylation was prevented by tunicamycin, individual bands of nonglycosylated vascular permeability factor were also secreted at equivalent rates, but much more slowly (approximately 60 min) than native glycoprotein. Both glycosylated and nonglycosylated forms of vascular permeability factor were equally potent at increasing dermal vessel permeability.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1930196     DOI: 10.1016/0006-291x(91)91752-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Association of serum VEGF levels with prefrontal cortex volume in schizophrenia.

Authors:  A Pillai; K R Howell; A O Ahmed; D Weinberg; K M Allen; J Bruggemann; R Lenroot; D Liu; C Galletly; C S Weickert; T W Weickert
Journal:  Mol Psychiatry       Date:  2015-07-14       Impact factor: 15.992

Review 2.  Tumor angiogenesis: the pivotal role of vascular endothelial growth factor.

Authors:  D Marmé
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

3.  Vascular endothelial growth factor in thyroid cyst fluids.

Authors:  Andrea Hofmann; Alois Gessl; Friedrich Girschele; Clemens Novotny; Oskar Kienast; Anton Staudenherz; Robert Dudczak; Shuren Li
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

4.  Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen.

Authors:  D T Shima; A P Adamis; N Ferrara; K T Yeo; T K Yeo; R Allende; J Folkman; P A D'Amore
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

5.  Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

Authors:  R A Berkman; M J Merrill; W C Reinhold; W T Monacci; A Saxena; W C Clark; J T Robertson; I U Ali; E H Oldfield
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

Review 6.  Vascular permeability factor (VPF, VEGF) in tumor biology.

Authors:  D R Senger; L Van de Water; L F Brown; J A Nagy; K T Yeo; T K Yeo; B Berse; R W Jackman; A M Dvorak; H F Dvorak
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

Review 7.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

Authors:  H F Dvorak; L F Brown; M Detmar; A M Dvorak
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

8.  Secretion of VEGF-165 has unique characteristics, including shedding from the plasma membrane.

Authors:  Maria Luisa Guzmán-Hernández; Gael Potter; Kristóf Egervári; Jozsef Z Kiss; Tamas Balla
Journal:  Mol Biol Cell       Date:  2014-02-05       Impact factor: 4.138

9.  Cytoprotective role of the fatty acid binding protein 4 against oxidative and endoplasmic reticulum stress in 3T3-L1 adipocytes.

Authors:  Kazuaki Kajimoto; Yoshitaka Minami; Hideyoshi Harashima
Journal:  FEBS Open Bio       Date:  2014-07-03       Impact factor: 2.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.